Trent Reutiman, Anaconda Biomed - Innovative Stroke Thrombectomy Technology | LSI USA '25

Anaconda Biomed is a pioneering medical device company specializing in advanced thrombectomy solutions to treat ischemic stroke. Leveraging state-of-the-art technology, they focus on improving patient outcomes with their innovative neurovascular products.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Trent Reutiman
Trent Reutiman
Chief Exectutive Officer, Anaconda Biomed